Characterization of peripheral blood stem cell grafts mobilized by granulocyte colony-stimulating factor and plerixafor compared with granulocyte colony-stimulating factor alone

Cytotherapy. 2013 Jul;15(7):861-8. doi: 10.1016/j.jcyt.2013.03.013.

Abstract

Background aims: This study aimed to characterize the immune effectors contained in apheresis samples obtained from patients with grafts mobilized with plerixafor and granulocyte colony-stimulating factor (G-CSF) (P+G) compared with grafts mobilized with G-CSF alone (G).

Methods: Aliquots of apheresis samples were obtained from 36 patients with malignant diseases after mobilization with G (n = 18) or P+G (n = 18). The phenotype and cytokine secretion profile of T cell and dendritic cell subsets were characterized by multicolor cytometry including intracellular cytokine staining.

Results: In grafts collected after mobilization with P+G, there was a significantly higher percentage of CD3(+) T cells compared with samples collected after mobilization with G alone. On a functional level, a significant increase of interferon-γ and tumor necrosis factor-α secreting CD8(+) T cells was observed in the P+G group compared with the G group. CD4(+)Foxp3(+) regulatory T cells were similar in both groups but exhibited a lower expression of inducible costimulatory molecule and a significantly higher expression of CD127 in the P+G group. Myeloid dendritic cells (MDCs) and BDCA3(+) dendritic cells were similar in both groups. In contrast, plasmacytoid dendritic cells (PDCs) (CD123(+)BDCA2(+)HLA-DR(+)) were significantly increased in the P+G grafts, leading to a higher PDC-to-MDC ratio. PDCs mobilized by P+G displayed different functional markers--a higher percentage of ILT7(+) PDCs and decreased expression of CD86--suggesting a potential regulatory capacity of PDCs mobilized by P+G.

Conclusions: Grafts mobilized with P+G exhibited major different functional features compared with grafts mobilized with G alone, suggesting that such grafts may have an impact on patient outcome after autologous stem cell transplantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antigens, Surface / metabolism
  • Benzylamines
  • Blood Component Removal / methods
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / metabolism
  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / metabolism
  • Child
  • Child, Preschool
  • Cyclams
  • Dendritic Cells / cytology*
  • Dendritic Cells / metabolism
  • Female
  • Forkhead Transcription Factors / metabolism
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Granulocyte Colony-Stimulating Factor / metabolism*
  • HLA-DR Antigens / immunology
  • Heterocyclic Compounds / administration & dosage
  • Heterocyclic Compounds / metabolism*
  • Humans
  • Interferon-gamma / metabolism
  • Male
  • Middle Aged
  • Peripheral Blood Stem Cell Transplantation*
  • Thrombomodulin
  • Transplants / drug effects
  • Transplants / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Antigens, Surface
  • Benzylamines
  • Cyclams
  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • HLA-DR Antigens
  • Heterocyclic Compounds
  • THBD protein, human
  • Thrombomodulin
  • Tumor Necrosis Factor-alpha
  • Granulocyte Colony-Stimulating Factor
  • Interferon-gamma
  • plerixafor